Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: NCT04401202 Eligibility Criteria

Page standards status: Informative
Metadata
Title NCT04401202 Eligibility Criteria
Identifier 189713
Steward (Publisher) Computable Publishing LLC
Description

Inclusion Criteria:

  • Patients with mild COVID19 upper respiratory tract infection and with no evidence of pneumonia
  • Adult (18 Years and above)
  • Written informed consent prior to initiation of any study procedures by the patient (or legally authorized representative).
  • Understands and agrees to comply with planned study procedures.
  • Has laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by polymerase chain reaction (PCR) available at KAUH. Exclusion Criteria:
  • Patients with pneumonia or severe illness requiring admission to ICU.
  • Severe chronic kidney disease (i.e. estimated glomerular filtration rate (eGFR) < 30) or end stage renal disease requiring dialysis
  • Sever chronic liver disease (Alanine transaminase/aspartate transaminase (ALT/AST) > 5 times the upper limit of normal).
  • Pregnancy or breast feeding.
  • Anticipated transfer to another hospital which is not a study site within 72 hours.
  • Allergy to any study medication.
Copyright

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
Generated using version 0.5.6 of the sample-content-ig Liquid templates